MONTREAL, QUEBEC--(MARKET WIRE)--Jun 7, 2007 -- Ambrilia Biopharma Inc. (Toronto:AMB.TO - News), a biopharmaceutical company developing novel small molecules and peptides to treat infectious diseases and cancer, announced today that it will hold its Annual General and Special Meeting of Shareholders on Thursday, June 14, 2007 at 10:30 a.m. ET at The Montreal Museum of Fine Arts, Auditorium Maxwell-Cummings, 1379 Sherbrooke Street West, Montreal, Quebec.
